Menopause and perimenopause, explained
Jillian Foglesong Stabile, MD
Board-certified Family Medicine · Diplomate, ABOM · Reviewed Jun 4, 2026
You are lying awake at 3 a.m., soaked through, heart going. Your period showed up twice this month, then skipped the next. You walked into the kitchen and forgot why. And when you finally said something to a doctor, you got a shrug and a “you seem fine.” Here is the truth: you are not imagining this. Your body is in the middle of one of the biggest hormonal shifts of your adult life, and almost nobody warned you it would feel like this. Let’s name what is happening, and what you can actually do about it.
The short version
Perimenopause is the years-long lead-up to menopause, when estrogen swings and drops. Menopause is one day, 12 months after your last period, on average around age 52. The years after are postmenopause. Most symptoms come from those hormone changes, and several treatments, hormonal and not, are proven to help.
What you will learn
- The three stages, what marks each one, and roughly when they hit
- The real symptom list, beyond hot flashes (sleep, mood, brain fog, painful sex)
- What the evidence says about hormone therapy in 2026, including the FDA’s big label change
- The proven non-hormonal options, including two brand-new ones
- How to get properly evaluated, and what to ask for
Chapter 01 · The stages
Your hormones are not “balanced,” and that is the whole point
Here is the part no one explains. Perimenopause is not a slow, smooth fade. It is a hormonal roller coaster. Estrogen does not glide down; it spikes high, then crashes low, sometimes in the same week. That chaos is why your symptoms feel random and why one “normal” blood test can miss it entirely.
What is the difference between perimenopause, menopause, and postmenopause?
Perimenopause is the transition: irregular cycles and symptoms while your ovaries wind down. Menopause is a single point in time, the day you hit 12 straight months with no period. Everything after that day is postmenopause. So technically, you spend one day “in menopause” and the rest of your life past it.
Think of it as three chapters:
- Perimenopause. Cycles get shorter, then longer, then unpredictable. Symptoms start. This is where most of the misery lives.
- Menopause. The 12-month marker. Confirmed only in the rearview mirror.
- Postmenopause. Hormones settle at a new, lower baseline. Some symptoms ease; others, like vaginal and urinary changes, often stick around or get worse without treatment.
Doctors use a research framework called STRAW+10 (the Stages of Reproductive Aging Workshop) to stage this more precisely. It tracks your bleeding pattern first, then hormone markers like FSH.11 You do not need to memorize it. You just need to know that your period pattern, not a single lab value, is the main clue.
Myth vs reality
Myth: You need a blood test to know if you are in perimenopause. Reality: For most women over 45 with classic symptoms, no test is required. Hormones swing so much day to day that one snapshot can read “normal” while you feel anything but.
When does this actually start?
Perimenopause usually begins in the mid-40s, with an average start around age 47, though anywhere from the early 40s to early 50s is normal.9 The transition lasts roughly four to seven years for most women, and sometimes up to eight.9 Menopause itself lands around age 52 on average, with a wide normal range from the mid-40s to the later 50s.10
One number worth holding onto: that is potentially close to a decade of change. Not a bad week. A chapter.
Chapter 02 · The symptoms
The symptoms are real, and there are more than you think
Most people can name two menopause symptoms: hot flashes and missed periods. The actual list runs to dozens, and many of them do not look like “menopause” at all. They look like anxiety, insomnia, joint pain, or a brain that suddenly will not cooperate.
What are vasomotor symptoms (hot flashes and night sweats)?
Vasomotor symptoms are the sudden waves of heat, flushing, and sweating, plus their nighttime version, night sweats. They are the signature symptom of the transition, driven by changes in the brain’s temperature-control center as estrogen drops.
How common are they? It varies hugely. A review of 66 studies across every continent found rates anywhere from 3% to 86%, depending on the population.12 For many women they are not a passing phase, either; they can last several years. Individual results vary, and yours may be milder or shorter than average.
Why can’t you sleep, even when you are exhausted?
Sleep falls apart for two reasons. Night sweats wake you up, and the hormone shifts disrupt sleep architecture directly, so you wake at 3 a.m. wired even on a cool night. The result is a tired-but-wired loop that feeds everything else.
And here is the chain reaction: bad sleep makes mood worse, makes brain fog worse, makes hot flashes feel less tolerable. Fix the sleep and other symptoms often loosen their grip. That is why a good clinician treats sleep as a lever, not an afterthought.
Is the brain fog and mood change in your head?
In your head, yes. Imagined, no. Estrogen helps regulate mood and supports memory and focus, so when it swings and drops, many women notice word-finding trouble, lost trains of thought, irritability, low mood, or new anxiety. For some, the mood piece is the loudest symptom of all.
A short list of what this can look like:
- Reaching for a word that will not come
- Walking into a room with no idea why
- Tearfulness or a short fuse that does not match the situation
- New or worsening anxiety, especially in the early hours
What is genitourinary syndrome of menopause (GSM)?
GSM is the cluster of vaginal and urinary changes caused by lower estrogen: dryness, burning, irritation, painful sex, urinary urgency, and repeat UTIs.8 Unlike hot flashes, which often fade with time, GSM tends to get worse without treatment.
This is the symptom women mention last, if at all. Painful sex, dryness, the UTIs that keep coming back. It is incredibly common, it is treatable, and there is nothing to be embarrassed about. Naming it is the only way to fix it.
How strong are your symptoms?
4-minute symptom check
Chapter 03 · What helps
What actually helps: the 2026 evidence, plainly
Good news, and it is genuinely new. The science and the official guidance around menopause treatment shifted in the last year. More options are proven, and the biggest one had a major regulatory update in February 2026. Let’s go through what works, starting with the most effective.
Is hormone therapy safe? What changed in 2026?
Hormone therapy is the most effective treatment for hot flashes, night sweats, and GSM, and for most healthy women under 60 and within 10 years of menopause, the benefits outweigh the risks.3 That is a real reversal from the fear many of us grew up with.
Here is the headline. On February 12, 2026, the FDA approved label changes removing the prominent “boxed warning” language about cardiovascular disease, breast cancer, and probable dementia from a first batch of six menopausal hormone therapy products (Prometrium®, Divigel®, Cenestin, Enjuvia, Estring®, and Bijuva®).1 The change followed a scientific review begun in November 2025.2
Why it matters: that warning came largely from a 2002 study whose findings were widely misread, and it scared a generation of women and doctors away from treatment that many would have benefited from. The 2026 update brings the label closer to what the evidence actually shows.
A few facts worth holding onto:
- The “timing window” is real. Starting hormone therapy within 10 years of menopause, or before age 60, is where the benefit-risk balance is most favorable.3
- The delivery method matters. Transdermal forms (patches, gels) and lower doses may carry less clot and stroke risk than pills for some women.4
- It is not for everyone. The decision depends on your history, and a clinician should personalize it with you. Individual results vary.
A note on “bioidentical” and compounded hormones
You will see a lot of marketing here. Custom-compounded hormones (made by a pharmacy from a patient-specific prescription, under 503A rules) are not the same as, and are not automatically safer than, FDA-approved products, and “natural” does not mean “lower risk.” If you and your clinician choose hormone therapy, a frank conversation about FDA-approved options belongs first.
What if you can’t or don’t want to take hormones?
You have proven non-hormonal options, and two of them are brand new. For women who cannot take estrogen, or simply prefer not to, the toolkit is the deepest it has ever been.
The newest arrivals target a brain pathway that helps trigger hot flashes:
- Fezolinetant (Veozah®). An FDA-approved non-hormonal pill for moderate-to-severe hot flashes. It carries a boxed warning about rare but serious liver injury, so monitoring matters.6
- Elinzanetant (Lynkuet). FDA-approved on October 24, 2025 as the first dual NK1/NK3 receptor option for moderate-to-severe hot flashes. In trials, moderate-to-severe hot flash frequency dropped about 74% by week 12, versus 47% on placebo.5
Other evidence-backed non-hormonal options:
- Low-dose paroxetine (Brisdelle). The first FDA-approved non-hormonal drug for hot flashes, an SSRI at a low dose.7 Other SSRIs and SNRIs are used off-label too.
- For GSM specifically, low-dose vaginal estrogen acts locally and does not raise blood estrogen beyond the normal menopausal range; non-hormonal vaginal moisturizers and lubricants help as well.8
These are prescription decisions. No one should start, stop, or dose any of them without a clinician. This is a menu to discuss, not a recommendation.
What about lifestyle, supplements, and the “quick fixes” online?
Lifestyle changes genuinely help around the edges: regular movement, protecting sleep, limiting alcohol and known hot-flash triggers, and strength training to defend muscle and bone. They support treatment; for moderate-to-severe symptoms, they rarely replace it.
Be skeptical of the viral stuff. Social feeds in 2026 are full of unproven “hacks,” and surveys show up to three-quarters of women feel dismissed when they seek perimenopause care, which is exactly the gap misinformation rushes to fill.12 If a fix sounds too easy and comes from someone selling it, slow down.
| Approach | Best for | Form | Worth knowing |
|---|---|---|---|
| Systemic hormone therapy | Hot flashes, night sweats, and broader symptoms | Patch, gel, pill | Most effective overall; best risk profile when started within 10 years of menopause or before 60 |
| Low-dose vaginal estrogen | GSM (dryness, painful sex, urinary symptoms) | Cream, ring, tablet | Acts locally; does not raise blood estrogen beyond normal menopausal range |
| Fezolinetant / elinzanetant | Moderate-to-severe hot flashes, non-hormonal | Pill | Newer brain-pathway drugs; fezolinetant carries a boxed liver-injury warning |
| Low-dose paroxetine + other SSRIs/SNRIs | Hot flashes, esp. if hormones are not an option | Pill | First FDA-approved non-hormonal hot-flash drug; some used off-label |
| Non-hormonal vaginal moisturizers / lubricants | Mild GSM, or a first step | OTC | Useful alone or alongside other treatment |
| Lifestyle (movement, sleep, alcohol limits, strength training) | Supporting any plan | Daily habits | Helps at the margins; rarely enough alone for moderate-to-severe symptoms |
Educational comparison. None of this is a prescription or a substitute for a clinician’s judgment. Swipe to see the full table on a phone.
Chapter 04 · Being heard
How to get evaluated without being dismissed
The hardest part is often not the biology. It is being heard. Too many women raise these symptoms and get sent home with a shrug. You can change the odds by walking in prepared and knowing what good care looks like.
What should a good evaluation actually include?
A solid menopause evaluation starts with your story: your cycle pattern, your symptoms, your medical and family history, and your goals. Lab tests are sometimes useful but are not required to diagnose perimenopause in most women over 45 with typical symptoms.
What good care looks like in practice:
- It takes your symptoms seriously instead of waving them off
- It lays out hormonal and non-hormonal options, with honest pros and cons
- It personalizes the plan to your history, not a one-size template
- It follows up, adjusts, and stays reachable when something is not working
That last point is where a lot of care quietly fails. Getting a prescription is the easy part. The follow-up, the dose check-in, the “this isn’t working, what now” conversation, is where real relief is won or lost.
Worth knowing
This is also a fair standard to apply to any online provider you consider. Before you hand over a card, a good women’s health provider shows you the full cost up front: the consultation fee, the medication cost, any lab cost, and the cancellation policy, with no charge until a clinician has reviewed and approved your care, and no surprise charges later. If a brand cannot tell you all of those numbers plainly, that tells you something. (This is the standard sipra is built around, and you can see how it works here.)
What questions should you bring to your appointment?
Bring a short list and you will get more out of any visit. A few that tend to open the right conversation:
- Based on my symptoms and history, am I a candidate for hormone therapy?
- If not, which non-hormonal options fit me?
- What are the risks and benefits for someone with my history specifically?
- How and when will we check whether this is working?
Not sure which stage you are in?
2-minute stage check
Your next three steps
You have read the whole thing, so here is where to put it. Three small moves, in order:
- Write down your symptoms and your cycle pattern. Two weeks of notes beats a foggy memory in any appointment.
- Pick one symptom that bothers you most and lead with it when you talk to a clinician. It anchors the conversation.
- Ask for a real evaluation, in person or online, and use the standard above: are you heard, are options laid out, is the plan personalized, is there follow-up.
You are not imagining this, and you do not have to white-knuckle through it. The evidence is better than it has ever been, and so are the options. The first step is simply being taken seriously.
Your hormones deserve better than guesswork
- Online visits with licensed physicians
- Estradiol, progesterone, HRT & sexual wellness
- Lab fees are included, no surprises
- FSA & HSA eligible with all plans
From$89/mo
+ Sipra membership*
*Price includes medication only. Active $99/mo Sipra membership required.
Frequently asked questions
Sources
- FDA. "FDA Approves Labeling Changes to Menopausal Hormone Therapy Products." February 12, 2026. fda.gov
- Harvard Health Publishing. "FDA removes menopause hormone therapy black box warnings." 2026. health.harvard.edu
- The Menopause Society. "The Menopause Society Comments on the FDA Announcement on Hormone Therapy." 2026. menopause.org
- Korean Society of Menopause. "The 2025 Menopausal Hormone Therapy Guidelines." 2025. pmc.ncbi.nlm.nih.gov
- Contemporary OB/GYN. "FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms." October 24, 2025. contemporaryobgyn.net
- FDA. "FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant)." 2024. fda.gov
- MGH Center for Women's Mental Health. "FDA Approves Nonhormonal Drug for Hot Flashes: Low-Dose Paroxetine (Brisdelle)." 2013. womensmentalhealth.org
- ACOG. "Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer." December 2021. acog.org
- Cleveland Clinic. "Perimenopause: Age, Stages, Signs, Symptoms & Treatment." Accessed 2026. my.clevelandclinic.org
- Mayo Clinic Press. "Explaining the stages of menopause." Accessed 2026. mcpress.mayoclinic.org
- Canadian Menopause Society. "Definition and Stages (STRAW+10)." Accessed 2026. canadianmenopausesociety.org
- npj Women's Health. "Perimenopause symptoms, severity, and healthcare seeking in women in the US." 2025. nature.com
- *Reviewed by a board-certified OB/GYN on the sipra medical network. Last reviewed June 4, 2026. This article is educational and is not medical advice, a diagnosis, or a treatment recommendation. Individual results vary. Talk with a licensed clinician about your situation.*
Trademark attribution. Brand names referenced (including Prometrium®, Divigel®, Estring®, Bijuva®, and Veozah®) are trademarks of their respective owners. sipra is not affiliated with or endorsed by these companies.
Medically reviewed by
Jillian Foglesong Stabile, MD, FAAFP, DABOM
Was this helpful?
Keep reading
Men's HealthErectile dysfunction treatment in 2026: the full menu, from pills to the combo approach
19 min read
Weight LossGLP-1 weight loss 101: how semaglutide and tirzepatide actually work
17 min read
Weight LossHow GLP-1 Treatment With sipra Works, Step by Step
16 min read
CompanyHow to Choose a Telehealth Provider You Can Trust: A 2026 Buyer's Checklist
16 min read
Weight LossThe Real Cost of GLP-1 Medication: Every Number Before Your Card Is Charged
16 min read
Weight LossBranded vs compounded GLP-1s: the real difference in 2026
9 min read
Weight LossGLP-1 Myths That Won't Die (and the Facts That Beat Them)
9 min read
Weight LossGLP-1 Side Effects and How to Manage Them, Week by Week
10 min read